BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Phase III Data Published in Lancet Show Novartis Pharmaceuticals Corporation Drug Zometa(R) Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients

  December 6, 2010

   · 

  12 min read
• St. Jude Children’s Research Hospital: Two Studies Provide Insight Into Stroke Risk and Prevention in Young Sickle Cell Anemia Patients

  December 6, 2010

   · 

  5 min read
• Drug Development

  Keryx Biopharmaceuticals: Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma

  December 6, 2010

   · 

  6 min read
• Drug Development

  Generex Biotechnology Corporation Presents New Positive AE37 Phase II Breast Cancer Vaccine Data

  December 6, 2010

   · 

  4 min read
• Drug Development

  Longer-term Phase III Data Show Novartis Corporation Drug Tasigna(R) Continues to Surpass Gleevec(R)

  December 6, 2010

   · 

  25 min read
• Drug Development

  Pharmacyclics, Inc. Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765

  December 6, 2010

   · 

  9 min read
• Biotech Bay

  diaDexus to Present at the Canaccord Genuity Healthcare Conference

  December 6, 2010

   · 

  1 min read
• Drug Development

  Cylene Pharmaceuticals, Inc. Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hypertension Meeting

  December 6, 2010

   · 

  3 min read
• Genetown

  Insulet Corporation to Present at the Canaccord Adams 5th Annual Cardiovascular, Diabetes and Obesity Conference

  December 6, 2010

   · 

  1 min read
• Drug Development

  H. Lundbeck A/S Says Clobazam Effective In Seizures in Phase 3 Study

  December 6, 2010

   · 

  7 min read